Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Xerox Attempts Hostile Takeover With New Tender Offer For HP

Published 03/02/2020, 08:24 PM
Updated 07/09/2023, 06:31 AM

Xerox Holdings Corporation (NYSE:XRX) yesterday launched a hostile takeover attempt with a $24-a-share tender offer to acquire all outstanding shares of HP (NYSE:HPQ) . The offer comprises $18.4 in cash and 0.149 Xerox shares for each HP share.

“Our proposal offers progress over entrenchment,” said Xerox chief executive officer John Visentin. “HP shareholders will receive $27 billion in immediate, upfront cash while retaining significant, long-term upside through equity ownership in a combined company with greater free cash flow to invest in growth and return to shareholders,” he added.

Xerox stated that it has secured financing from Citigroup (NYSE:C) , Bank of America (NYSE:BAC) , Mizuho Financial Group, Mitsubishi UFJ Financial Group, Credit Agricole (PA:CAGR), SunTrust Robinson Humphrey, Truist Financial and PNC Bank for the cash portion.

HP said that it will review the offer over 10 business days before deciding a course of action for shareholders.

The Tug of War

Xerox has been considering the buyout since May 2019 and revealed its takeover offer in November with a $22 per share bid. HP had rejected the offer, stating that the deal was undervalued and Xerox didn’t adequately explain its financial situation.

Xerox, in early February, increased the deal price to $24 a share and stated that it would launch a tender offer in March. HP went for “poison pill” defense, giving its shareholders the right to buy more shares at a discount if any individual or group acquires 20% of its outstanding shares. Thus, no one could accumulate more than 20% stake in the company.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

To further complicate the situation, a HP sec filing last Thursday revealed that Activist investor Carl Icahn had intentions to buy the company if it didn’t pursue merger with Xerox.

What if They Merge?

Both the companies have been grappling with decreased demand for paper-related systems in an increasingly digital environment. Both lack certain capabilities that could be useful in a shrinking market.

Labels, packaging and signage for instance are fast growing areas of the market where HP shines but Xerox doesn’t have any offering. Similarly, the corporate copier business is where Xerox shines while HP has no presence.

So, if the merger materializes, it will enable Xerox to create a strong portfolio capable of catering to a wide range of printing needs.

Xerox earlier said that it expects the proposed combination to produce $2 billion in cost savings and more than $1 billion in additional revenue growth.

Both Xerox and HP sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Shares of Xerox and HP have increased a respective 14.3% and 19.1% over the past six months, outperforming the 5.5% rally of the Zacks S&P 500 composite.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See these 7 breakthrough stocks now>>



HP Inc. (HPQ): Free Stock Analysis Report

Bank of America Corporation (BAC): Free Stock Analysis Report

Citigroup Inc. (C): Free Stock Analysis Report

Xerox Corporation (XRX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.